scispace - formally typeset
M

Maddur Srinivas

Researcher at All India Institute of Medical Sciences

Publications -  87
Citations -  1121

Maddur Srinivas is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Population & Tracheoesophageal fistula. The author has an hindex of 17, co-authored 84 publications receiving 967 citations. Previous affiliations of Maddur Srinivas include Our Lady's Children's Hospital.

Papers
More filters
Journal ArticleDOI

Revised guidelines on management of antenatal hydronephrosis.

TL;DR: The present guidelines update the recommendations published in 2000 and clarify the role of prenatal intervention, frequency of follow-up investigations and indications for surgery in patients with Antenatal hydronephrosis.
Journal ArticleDOI

Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.

TL;DR: In this article, the results of percutaneous nephrostomy (PCN) in all patients with ureteropelvic junction obstruction (UPJO) and split renal function (SRF) of less than 10%, because the management of such cases is still under debate.
Journal ArticleDOI

Association between lower hair zinc levels and neural tube defects.

TL;DR: In this article, a study was designed to evaluate zinc status of the newborn babies with NTD and their mothers, and the results showed that zinc deficiency was associated with decreased hair zinc levels.
Journal ArticleDOI

Apoptosis and cell removal in the cryptorchid rat testis

TL;DR: It is indicated that Declined intra testicular testosterone, elevated temperature and high oxidative stress following cryptorchidism probably affect cell viability and trigger a fast pace cell removal through giant cell formation.
Journal ArticleDOI

Gastric teratoma in children.

TL;DR: Both the mature and immature types of GT have an excellent prognosis after complete excision of the tumor, and even when the immature type infiltrates surrounding structures,complete excision offers recurrence-free survival without requiring chemo- or radiotherapy.